Concentrations of alpha- and beta-defensins in plasma of patients with inflammatory bowel disease

Inflamm Res. 2009 Apr;58(4):192-7. doi: 10.1007/s00011-008-8120-8.

Abstract

Background: Impaired production/release of defensins, representative endogenous antimicrobial peptides, is associated with the pathogenesis of inflammatory bowel disease (IBD).

Material and methods: Employing in house radioimmunoassay, we examined concentrations of the major forms alpha-defensins, human neutrophil peptides (HNP) 1-3 and human beta-defensin (HBD)-2 in plasma of 55 IBD patients consisting of 29 patients with ulcerative colitis (UC) and 26 with Crohn's disease (CD) and 57 controls.

Results: The circulating HNP 1-3, but not HBD-2, levels in IBD patients were significantly higher than those in controls. Plasma HNP 1-3 concentrations in CD patients significantly correlated with Crohn's disease activity index, peripheral white blood cell counts, serum CRP values and TNF-alpha levels.

Conclusions: Elevation of circulating alpha-defensins levels is suggestive of their physiopathological roles in IBD. Plasma HNP 1-3 concentrations may be an indicator for CD activity and their association with CRP and TNF-alpha supports a possible association with the inflammatory process.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Infective Agents / blood
  • Female
  • Humans
  • Inflammatory Bowel Diseases / blood*
  • Inflammatory Bowel Diseases / pathology
  • Inflammatory Bowel Diseases / physiopathology
  • Male
  • Middle Aged
  • Severity of Illness Index
  • Statistics as Topic
  • Young Adult
  • alpha-Defensins / blood*
  • beta-Defensins / blood*

Substances

  • Anti-Infective Agents
  • alpha-Defensins
  • beta-Defensins